2024-09-01 - Analysis Report
## HCA Stock Analysis Report

**Company Overview:** HCA Healthcare, Inc. is one of the largest for-profit healthcare providers in the United States, operating hospitals and other healthcare facilities across the country.

**Performance Analysis:**

**1. Relative Performance:**

* **Cumulative Return:** HCA has generated a cumulative return of 170.42% compared to 89.66% for the S&P 500 (VOO) over the analyzed period.
* **Relative Outperformance:** HCA significantly outperformed the S&P 500, currently sitting at a relative outperformance level of 100% based on historical data. This means HCA's performance is at the highest point of its historical outperformance range compared to the S&P 500.

**2. Recent Price Action:**

* **Closing Price:** $395.59
* **Moving Averages:** HCA is currently trading above all three moving averages, indicating potential upward momentum:
    * 5-day moving average: $391.45
    * 20-day moving average: $373.99
    * 60-day moving average: $348.09

**3. Technical Indicators:**

* **RSI:** 99.19 - HCA's RSI is in overbought territory, suggesting the stock is likely overvalued and could be due for a correction.
* **PPO:** 0.22 - The PPO is positive, indicating potential upside momentum, but it's near its highs, suggesting it might be nearing a peak.
* **Delta_Previous_Relative_Divergence:** +13.51 -  The positive Delta_Previous_Relative_Divergence suggests short-term bullish momentum.

**4. Recent Earnings & Outlook:**

| Date     | EPS     | Revenue           |
|----------|---------|-------------------|
| 2024-07-29 | 5.6    | 17.49 B$        |
| 2024-05-02 | 6.01    | 17.34 B$        |
| 2023-10-26 | 3.98    | 16.21 B$        |
| 2023-08-02 | 4.35    | 15.86 B$        |
| 2023-07-29 | 4.35    | 15.86 B$        |

HCA's recent earnings have been strong, exceeding analyst expectations in most quarters. The company's strong performance has been attributed to factors like increased patient volume and efficient cost management.  However, it is important to note that the current high valuation and overbought condition on the stock chart may present risks to future returns.

**5. Summary & Conclusion:**

HCA has significantly outperformed the S&P 500 in recent times, with its stock currently trading at high valuations. Although recent earnings have been strong and technical indicators suggest short-term bullish momentum, the RSI and PPO both indicate potential overbought conditions, which may present risks to the stock's future performance. Investors should carefully consider these factors before making any investment decisions. 
